Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
58.10
-0.81 (-1.38%)
Jan 23, 2025, 12:08 PM EST - Market open
Belite Bio Employees
Belite Bio had 20 employees as of December 31, 2023. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,651,700
Market Cap
1.79B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20 | 4 | 25.00% |
Dec 31, 2022 | 16 | 4 | 33.33% |
Dec 31, 2021 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
BLTE News
- 2 months ago - Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 - GlobeNewsWire
- 2 months ago - Belite Bio, Inc. (BLTE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer - GlobeNewsWire
- 5 months ago - Belite Bio, Inc (BLTE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 6 months ago - Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewsWire